Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Vascular Genesis logo — company profile

Vascular Genesis

Founded 2016 United States Columbus, United States 1 employees Seed Biotechnology, Life Sciences

General Information

Company Name Vascular Genesis
Founded Year 2016
Location United States Columbus, United States
Employees 1
Industries Biotechnology, Life Sciences
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Vascular Genesis. To contact Vascular Genesis, visit vasculargenesis.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Vascular Genesis compare?

A PDF of Vascular Genesis and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Vascular Genesis soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Vascular Genesis

Vascular Genesis is a biotechnology startup based in the United States, founded in 2016. The company is focused on revolutionizing the vascular conduit replacement market with its innovative line of synthetic scaffold products. These products boast self-healing capabilities that significantly lower the risks associated with traditional vascular conduit replacements, including rejection, infection, and stenosis. The company's most recent milestone was its Seed Round investment on 30 May 2017, where it secured funding from Ikove Capital Partners, John D'Orazio, and Proton Enterprises. Vascular Genesis's technology and products address critical needs in the medical device industry, offering promising solutions to enhance patient outcomes and minimize potential complications. With a strong focus on innovation and product development, the company has the potential to make a significant impact in the field of vascular health and could attract further interest from investors and strategic partners in the biotechnology and medical sectors.

Business keywords: Medical Device, MedTech, Vascular Conduit Replacement, Synthetic Scaffold, Self-healing Capabilities, Rejection Risk Reduction, Infection Risk Reduction, Stenosis Risk Reduction, Regenerative Medicine, Tissue Regeneration, Medical Technology, Healthcare Innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 3
Ikove Capital Partners
Ikove Capital Partners, John D'Orazio +1
30 May 2017

Vascular Genesis Alternatives & Competitors

View All Alternatives
Vascular Genesis vs
TherageniX
TherageniX

Tissue regeneration via gene therapy

Grant
2 employees
Biotechnology, Health Care
Vascular Genesis vs
Rapid Nexus Nanotech Wound Solutions, Inc.
Rapid Nexus Nanotech Wound Solutions, Inc. United States

The first company to develop a novel peripheral neuropathy tissue healing product.

6 employees
Biotechnology, Health Care
Vascular Genesis vs
osteobionix
osteobionix Spain

From replacement to regeneration

11 employees
Biotechnology, Health Care
View all alternatives

FAQ About Vascular Genesis

Vascular Genesis is a medical device company revolutionizing the vascular conduit replacement market with its line of synthetic scaffold products with self-healing capabilities that lower the risk of rejection, infection, and stenosis.
Vascular Genesis was founded in 2016.
Vascular Genesis is headquartered in Columbus, United States.
Vascular Genesis operates in Biotechnology and Life Sciences. Its work centres on Medical Device, MedTech, Vascular Conduit Replacement and Synthetic Scaffold.
Vascular Genesis has approximately 1 employees.
Vascular Genesis has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to Vascular Genesis include TherageniX, Rapid Nexus Nanotech Wound Solutions, Inc., osteobionix, BioTissue SA, Morphoceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vascular Genesis and TherageniX are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Vascular Genesis, https://bouncewatch.com/company/vascular-genesis, updated 2 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes